Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - TI FLUID SYSTEMS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AVIVA PLC - Ordinary Shares
-
SHARE BUYBACK TRANSACTIONS, PROGRAMME COMPLETED
-
EfTEN Real Estate Fund AS invites to webinars introducing the offering of new additional shares
-
Man Group PLC : Form 8.3 - TI Fluid Systems plc
-
Man Group PLC : Form 8.3 - International Distribution Services plc
-
Nova Klúbburinn hf.: Framkvæmd endurkaupaáætlunar í viku 48
-
Landsbankinn hf.: Buy-back offer of Tier 2 bonds
-
Prepayments, Realkredit Danmark A/S
-
Danske Bank share buy-back programme: Transactions in week 48
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Preliminary data on early redemptions (prepayments)
-
Heimar hf.: Regular Notification of Share Buybacks in Accordance with the Buyback Program
-
Alm. Brand A/S – Weekly report on share buybacks
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Rhombus Expands Global Presence with New UK Office Amid Rising Demand for Cloud-Managed Physical Security
-
Share buyback programme - week 48
-
Registration of share capital increase of 24,554,416 new shares completed
-
Quantexa Welcomes Hiek Van der Scheer to Advisory Board
-
IDEX Biometrics ASA: Mandatory notification of subscription by primary insider – 2 Dec 2024
-
Aspo’s subsidiary Leipurin expands its food ingredients business in the Baltics
-
DNO Strikes Oil in New Play Offshore Norway
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 4)
-
TextMagic AS payout related to share capital reduction
-
Total voting rights
-
AAVantgarde Bio Announces FDA Orphan Drug Designation for AAVB-081 for the Treatment of Usher Syndrome Type 1B Retinitis Pigmentosa
-
Dividend payment ex-date of Arco Vara AS
-
Press Release: Sequana Medical announces update on second tranche of convertible bridge loan
-
Updated first day of trading in BTAs and subscriptions rights
-
Annual General Meeting to approve the 2023 financial statements to be held on January 31, 2025 at 10:00am CET at the Company’s headquarters
-
Intermediate Capital Group plc :
-
Voting Rights and Capital
-
deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test
-
Transaction in Own Shares
-
Subsea7 share repurchases
-
Digital ID Verification Spend to Exceed $26 billion Globally by 2029
-
Total Voting Rights and Capital
-
CGPH Banque D'Affaires Unveils New Website Offering Exclusive Investment Opportunities
-
Enlight Research updated equity research on EfTEN Real Estate Fund AS
-
Sampo completes its share buyback programme
-
Ipsos: Information relating to a potential acquisition of Kantar Media
-
NKT updates medium-term financial ambitions
-
Atos completes the sale of Worldgrid to ALTEN for an enterprise value of €270 million
-
Bureau Veritas completes the acquisition of The APP Group, strengthening its Buildings & Infrastructure leadership position in Asia-Pacific
-
Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected
-
Sampo plc’s share buybacks 29 November 2024
-
Completion of the sale of 17% of France Billet by Fnac Darty to CTS Eventim
-
Start of Day Message
